Project Twenty21 is the largest observational medical cannabis study in the UK, gathering data on the efficacy of cannabis-based medicines for a wide range of conditions.
You help us move closer to our ultimate goal of access to medical cannabis on the NHS by providing us with your data. We do this by asking patients to fill out a few questionnaires once every 3 months.
You’re in safe hands, with some of the UK’s leading medical cannabis clinicians prescribing at our participating clinics.
You can trust that your prescribed product will be high quality, as the study is supported by multiple industry partners offering EU GMP-certified products.
Drug Science is completely independent and observational, so there is no bias when it comes to which clinic you choose or what you will be prescribed.
We have worked with the licensed-producers to offer competitive prices on all Twenty21 products.
Project Twenty21 allows eligible patients to access medical cannabis treatment at a capped price, and have their treatment tracked by Drug Science.
Drug Science will use the data from Project Twenty21 to provide evidence for NHS funding of medical cannabis treatment.
Medical cannabis treatment starts with a private consultation between you and a specialist doctor from a Project Twenty21-approved cannabis clinic
During the consultation, your doctor will be happy to discuss any medical cannabis treatment which suits your needs.
Once your prescription has been approved, the pharmacy will contact you for payment before your medication is sent to your house.
You must have a diagnosed condition that can be treated with medical cannabis to join Project Twenty21. Select your condition below to choose a suitable Project Twenty21 clinic.
You don’t need a referral from your doctor to make an appointment, but you will need to provide medical records or referral letter from your specialist – the clinic can help you with this.
Some clinics may have additional eligibility criteria such as having tried two other forms of treatment or therapies for your condition which have proven ineffective.
o Arthritis
o Back and/or neck pain
o Complex regional pain syndrome (CRPS)
o Ehlers-Danlos Syndromes (EDS)
o Endometriosis
o Fibromyalgia
o Musculoskeletal pain (MSK)
o Neuropathic pain
o Other condition that causes chronic pain
o Autism spectrum disorder (ASD)
o ADHD
o Cluster headaches
o Epilepsy
o Migraines
o Multiple Sclerosis
o Muscle spasms
o Parkinson’s disease
o Tourette’s syndrome
o Tremors
o Stroke
o Agoraphobia
o Appetite disorders (ex. anorexia)
o Generalised Anxiety Disorder (GAD)
o Insomnia/sleep disorders
o Major Depressive Disorder (Depression)
o Obsessive Compulsive Disorder (OCD)
o Panic disorder
o Post-Traumatic Stress Disorder (PTSD)
o Social anxiety disorder (social phobia)
o Substance Use Disorder
o Other condition that causes anxiety
o Crohn’s and/or ulcerative colitis
o Irritable bowel syndrome (IBS)
o Cancer-related anxiety
o Cancer-related appetite loss
o Cancer-related depression
o Cancer-related pain
o Chemotherapy induced nausea and vomiting
End of life care is support for people who are in the last months or years of their life.
o Chronic Fatigue Syndrome/ME
o Restless legs syndrome
| Price Guide | |
|---|---|
| Initial Consultation | £70 – £250 |
| Follow-up Consultation | £49 – £195 |
| Twenty21 Flower | £65 – £150 |
| Twenty21 Oil | Up to £150 |
| Repeat Prescription | Up to £30 |
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
